|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61K 31/506 | (2013.01) | ||
| A61K 31/404 | (2006.01) | ||
| C07D 403/04 | (2013.01) | ||
| C07D 239/42 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07D 401/04 | (2006.01) |
| (11) | Patento numeris | 3638241 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18817811.5 |
| Europos patento paraiškos padavimo data | 2018-06-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-05-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/037744 |
| Data | 2018-06-15 |
| (87) | Numeris | WO 2018/232235 |
| Data | 2018-12-20 |
| (30) | Numeris | Data | Šalis |
| 201762521007 P | 2017-06-16 | US |
| (72) |
GRECO, Michael, Nicholas , US
COSTANZO, Michael, John , US
GREEN, Michael, Alan , US
PENG, Jirong , US
WILDE, Victoria, Lynn , US
ZHANG, Don , US
|
| (73) |
Beta Pharma, Inc. ,
1000 N. West Street
Suite 1200, Wilmington, DE 19801,
US
|
| (54) | PHARMACEUTICAL FORMULATIONS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND SALTS THEREOF |
| PHARMACEUTICAL FORMULATIONS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND SALTS THEREOF |